Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Invesco Ltd.’s (IVZ - Analyst Report) fourth-quarter adjusted earnings came in at 45 cents per share, marginally missing the Zacks Consensus Estimate of 47 cents. Yet, this compares favorably with adjusted earnings of 42 cents recorded in the previous quarter.
Lower-than-expected quarterly results came on the back of a rise in operating costs, partly offset by higher net revenue. Further, improved assets under management (AUM) and stable balance sheet position were the tailwinds.
On a GAAP basis, net income in the fourth quarter stood at $158.7 million or 35 cents per share, down from $170.6 million or 38 cents in the prior quarter. For 2012, it was $677.1 million or $1.49 per share, down from $729.7 million or $1.57 per share in 2011.
For 2012, adjusted earnings per share were $1.71, slightly below the Zacks Consensus Estimate of $1.74. Yet, this was up 1.8% from $1.68 in 2011.
Behind the Headlines
Adjusted net revenue grew 5.6% sequentially to $775.9 million in the reported quarter. Increases in investment management fees and performance fee revenues were the primary reasons behind the rise. However, net revenue was nowhere near the Zacks Consensus Estimate of $1.11 billion.
For 2012, adjusted net revenue was recorded at $3.0 billion, up 2.1% year over year. Yet, it was substantially below the Zacks Consensus Estimate of $4.25 billion.
Adjusted operating expenses hiked 3.1% from the prior quarter to $499.4 million. The increase was primarily attributable to higher employee compensation expenses and general and administrative expenses, partially offset by lower marketing expenses.
Adjusted operating margin for the quarter was 35.6%, rising from 34.1% in the prior quarter.
Assets Under Management
As of Dec 31, 2012, AUM inched up 0.7% sequentially to $687.7 billion, reflecting net market gains, partially offset by unfavorable foreign exchange rate changes. Average AUM for the reported quarter was $680.2 billion, up 1.8% from $667.9 billion in the prior quarter.
Long-term net inflows during the quarter were $0.9 billion compared with $9.4 billion in the preceding quarter.
Balance Sheet
As of Dec 31, 2012, cash and cash equivalents were $835.5 million compared with $727.4 million as of Dec 31, 2011. Total debt was $1,186.0 million as of Dec 31, 2012, against $1,284.7 million as of Dec 31, 2011.
Additionally, credit facility balance reached $586.5 million as of Dec 31, 2012, compared with $754.5 million as of Sep 30, 2012.
Share Repurchase Update
During the reported quarter, Invesco repurchased $75 million worth of shares, representing 3.0 million shares. For 2012, the company repurchased shares worth $265.0 million.
Dividend Update
Concurrent with the earnings release, the company declared third-quarter dividend of 17.25 cents per share. The dividend will be paid on Mar 8 to shareholders of record as of Feb 21.
Peer Performances
Fourth-quarter earnings of BlackRock Inc. (BLK - Analyst Report) and Ameriprise Financial Inc. (AMP - Analyst Report) substantially exceeded the Zacks Consensus Estimate, while SEI Investments Co. (SEIC - Analyst Report) reported in line. For all these 3 companies, the year-over-year improvement was primarily attributable to increased top line, partly offset by higher operating expenses.
Our Viewpoint
Invesco’s long-term investment performance was boosted by an uptrend in the global equity markets, which is envisioned to uplift the company’s operating results. Moreover, the operating leverage is expected to improve significantly over the long term due to Invesco’s cost-control initiatives.
Invesco is well positioned to benefit from improved global investment flows owing to its broad diversification. Also, meaningful capital deployment activities will enhance shareholders confidence in the stock. However, volatile U.S. dollar and increasing competition remain the major areas of concern.
Invesco currently retains a Zacks Rank #3 (Hold).
Get the full Analyst Report on IVZ - FREE
Get the full Analyst Report on AMP - FREE
Get the full Analyst Report on BLK - FREE
Get the full Analyst Report on SEIC - FREE